Edwards Lifesciences Investor Relations Material
Latest events
Q1 2025
Edwards Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Edwards Lifesciences Corporation
Access all reports
Edwards Lifesciences Corporation is an innovative medical-device company, providing products in structural heart disease, and critical care and surgical monitoring that can improve healthcare worldwide. Our comprehensive portfolio includes devices for chronic total occlusions (CTO) repair and treatment of mitral valve disease (MVD). We also design and manufacture mechanical circulatory support devices, including the bioresorbable percutaneous ventricular assist device (BiVAD(TM)) used in advanced heart failure. Edwards Lifesciences Corporation is based in Irvine, California.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
EW
Country
🇺🇸 United States